Claritev Corp. (CTEV)
29.65
+2.65
(+9.81%)
USD |
NYSE |
May 11, 16:00
29.78
+0.13
(+0.44%)
After-Hours: 20:00
Claritev EPS Diluted (Quarterly) : -4.407 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Doximity, Inc. | 0.309 |
| DarioHealth Corp. | -2.332 |
| Retrieve Medical Holdings, Inc. | -0.0304 |
| American Well Corp. | -0.6562 |
| GoodRx Holdings, Inc. | 0.0034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.56M |
| Revenue (Quarterly) | 244.68M |
| Total Expenses (Quarterly) | 318.24M |
| Enterprise Value | 5.211B |
| Gross Profit Margin (Quarterly) | 26.36% |
| Profit Margin (Quarterly) | -30.06% |
| Earnings Yield | -58.42% |
| Operating Earnings Yield | 7.10% |
| Normalized Earnings Yield | -58.35 |